Year None202220212020 February 15, 2022 LianBio Announces Mavacamten Granted Breakthrough Therapy Designation in China January 10, 2022 LianBio Announces First Patient Dosed in Registrational Phase 3 EXPLORER-CN Trial of Mavacamten in Chinese Patients with Obstructive Hypertrophic Cardiomyopathy Pagination First page « first Previous page ‹ previous Page 1 Page 2 Current page 3 Displaying 21 - 22 of 22
January 10, 2022 LianBio Announces First Patient Dosed in Registrational Phase 3 EXPLORER-CN Trial of Mavacamten in Chinese Patients with Obstructive Hypertrophic Cardiomyopathy
